Piper Jaffray Downgrades Allscripts (MDRX) to Underweight

Go back to Piper Jaffray Downgrades Allscripts (MDRX) to Underweight

Allscripts (MDRX) Tops Q3 EPS by 5c; Withdrawing Guidance; to Evaluate Alternatives

November 8, 2012 4:06 PM EST

Allscripts (NASDAQ: MDRX) reported Q3 EPS of $0.23, $0.05 better than the analyst estimate of $0.18. Revenue for the quarter came in at $360.7 million versus the consensus estimate of $372.35 million.

The company is withdrawing guidance.

CEO Glen Tullman continued, "We are... More